In particular, hyperactivation of the NF-κB pathway permits tumor-selective reprogramming of the chemokine microenvironment, and this reprogramming greatly enhances the recruitment of effector CD8(+) T cells, which in turn leads to the generation of potent anti-CRC effects [59, 60]. This evidence concerns the gene CD8A and neoplasm.